Gut microbes implicated in bladder cancer

byEuropean Molecular Biology LaboratoryA science illustrator depicts how the carcinogen BBN (left) is affected by gut bacteria and then metabolized to BCPN (right) and distributed in the body, l

Nephrology & Urology August 27,2024 0

Gut microbes implicated in bladder cancer

byEuropean Molecular Biology LaboratoryA science illustrator depicts how the carcinogen BBN (left) is affected by gut bacteria and then metabolized to BCPN (right) and distributed in the body, l

Nephrology & Urology August 27,2024 0

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Oncology August 27,2024 0

Research: Insufficient evidence to recommend low-dose CT screening in never smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early

Oncology August 27,2024 0

Study finds nearly half of top cancer centers required universal masking during last winter's COVID-19 surge

byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du

Oncology August 27,2024 0

Study finds nearly half of top cancer centers required universal masking during last winter's COVID-19 surge

byTulane UniversityCredit: Unsplash/CC0 Public DomainNearly half of the nation's National Cancer Institute (NCI)-designated cancer centers required universal masking in key clinical areas du

Oncology August 27,2024 0

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Oncology August 27,2024 0

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Oncology August 27,2024 0

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Oncology August 27,2024 0

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Oncology August 27,2024 0

Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-care

byWileyCredit: Unsplash/CC0 Public DomainSince the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, surv

Oncology August 27,2024 0

Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-care

byWileyCredit: Unsplash/CC0 Public DomainSince the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, surv

Oncology August 27,2024 0

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Oncology August 27,2024 0

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Oncology August 27,2024 0

Most Americans don't know about lung cancer screening, survey shows

by Ernie MundellCredit: Anna Tarazevich from PexelsPeople who've had a history of smoking can get alung cancerspotted early—when it's most treatable—through annual CT screening.Unf

Oncology August 27,2024 0

Most Americans don't know about lung cancer screening, survey shows

by Ernie MundellCredit: Anna Tarazevich from PexelsPeople who've had a history of smoking can get alung cancerspotted early—when it's most treatable—through annual CT screening.Unf

Oncology August 27,2024 0

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Oncology August 27,2024 0

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Oncology August 27,2024 0

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Oncology August 27,2024 0

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Oncology August 27,2024 0